Biosimilars access, interchangeability, and payer economics take center stage
STAT’s biosimilars event focused on access barriers, interchangeability policy, and payer economics shaping affordability and supply predictability.
By Dr. A. Nikhil Krishnan, MBBS
·
Oct 17, 2026
·
5 min read